Skip to content

Organon OGN Other Non-Current Assets

Other Non-Current Assets at other companies

Amgen logo
AmgenAMGN
$12.76B+12.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$672.8M+2.1%
Biogen logo
BiogenBIIB
$777.5M+39.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$54.88M+20.8%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$8.7M+89.1%
PBH
Prestige Consumer HealthcarePBH
$10.87M+232%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's other non-current assets?
Organon (OGN) reported other non-current assets of $1.53B in Q1 2026.
How has Organon's other non-current assets changed year-over-year?
Organon's other non-current assets increased by 2.8% year-over-year, from $1.49B to $1.53B.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.